Earnings History Data for Werewolf Therapeutics (HOWL) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Werewolf Therapeutics
Werewolf Therapeutics Inc. is a biopharmaceutical company. It involved in the development of conditionally activated therapeutics engineered to stimulate the body's immune system for the treatment of cancer. Werewolf Therapeutics Inc. is based in CAMBRIDGE, Mass.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 07-03-2024 | PM | HOWL | Werewolf Therapeutics | 278.00 | -0.33 | -0.43 | 0.00 | Werewolf Therapeutics GAAP EPS of -$0.33, revenue of $1.5M [3/7/2024 11:27 AM] |
6.74 | -0.29 (-4.13%) |
0.0 | 0.0 (0.00%) |
1.57 - 8.19 | 173,232 | 210,000 | 0 | ||
| 14-11-2023 | AH | HOWL | Werewolf Therapeutics | 82.00 | -0.23 | -0.27 | 0.00 | Werewolf Therapeutics GAAP EPS of -$0.23, revenue of $5.9M [11/14/2023 5:02 PM] |
2.18 | -0.02 (-0.91%) |
2.28 | 0.08 (3.64%) |
1.39 - 4.57 | 165,580 | 4,680,000 | 10,972 | ||
| 11-05-2023 | PM | HOWL | Werewolf Therapeutics | 106.00 | -0.34 | -0.49 | 0.00 | 2.78 | -0.26 (-8.55%) |
0.0 | 0.0 (0.00%) |
1.39 - 7.51 | 17,499 | 40,000 | 0 | |||
|
|
||||||||||||||||||
| 10-11-2022 | PM | 7:00 AM ET (Nov 10) |
HOWL | Werewolf Therapeutics, Inc. | 70.28 | -0.40 | -0.60 | -0.51 | Werewolf Therapeutics GAAP EPS of -$0.40 beats by $0.20, revenue of $4.97M beats by $0.9M [11/10/2022 9:26 AM] |
2.29 | 0.07 (3.38%) |
0.0 | 0.0 (0.00%) |
2.16 - 16.50 | 24,485 | 80,000 | 0 | |
|
||||||||||||||||||
| 10-05-2022 | PM | 7:00 AM ET (May 10) |
HOWL | Werewolf Therapeutics | 145.00 | -0.56 | -0.60 | 0.00 | Werewolf Therapeutics GAAP EPS of -$0.56 beats by $0.05 [5/10/2022 7:55 AM] |
6.10 | 0.71 (13.16%) |
5.59 | 0.20 (3.71%) |
3.51 - 21.67 | 144,083 | 339,035 | 129 | |
| 24-03-2022 | PM | HOWL | Werewolf Therapeutics, Inc. | 117.49 | -0.66 | -0.56 | 0.00 | Werewolf Therapeutics GAAP EPS of -$0.66 misses by $0.10 [3/24/2022 7:28 AM] |
3.63 | -0.25 (-6.44%) |
3.90 | 0.02 (0.52%) |
3.51 - 23.99 | 82,524 | 71,040 | 242 | ||
| 10-11-2021 | PM | HOWL | Werewolf Therapeutics | 433.00 | -0.51 | -0.45 | 0.00 | Werewolf Therapeutics reports Q3 results [11/10/2021 9:06 AM] |
16.01 | 0.28 (1.78%) |
0.0 | 0.0 (0.00%) |
11.23 - 23.99 | 18,668 | 40,000 | 0 | ||
| 12-08-2021 | PM | 7:00 AM ET (Aug 12) |
HOWL | Werewolf Therapeutics, Inc. | 413.00 | -3.82 | -0.28 | 0.00 | Werewolf Therapeutics EPS misses by $3.55 [8/12/2021 8:47 AM] |
15.22 | 0.25 (1.67%) |
15.22 | 0.0 (0.00%) |
11.23 - 23.99 | 25,036 | 20,000 | 637 | |